HIGHLIGHTS
- who: D. Southcott md et al. from the bone agents, including denosumab, to, weekly therapy is a reasonable clinical strategyTable i summarizes the administration schedules and doses for those commonly used agents. Table ii shows estimated prices for btas in Canada have published the article: SPECIAL ARTICLE, in the Journal: (JOURNAL)
- what: BTAs FOR METASTASES TO BONE Types of BTAs For the purposes of this review, the authors focus on the two types of bta s that are approved for use in clinical practice: bisphosphonates and denosumab.
SUMMARY
Bone is the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.